Home / News / Hartmann 2013 sales exceeds previous year's record

Hartmann 2013 sales exceeds previous year's record

28 Mar '14

3 min read

With sales revenues of EUR 1,794 million in fiscal year 2013, the HARTMANN GROUP exceeded its previous year's record sales. Excluding exchange-rate and acquisition effects, organic growth was 3.5% and therefore above market growth.

The positive sales performance but also increased sales of higher margin products and further productivity improvement have contributed to the company’s continued profitable growth. In the year under review, EBIT increased 12.5% to EUR 102.1 million. The consolidated net income was EUR 62.5 million, an increase of 11.9% compared to the previous year.

Sales in the Wound Management segment were EUR 485.8 million in the year under review, an increase of 2.6% compared to the previous year, or 3.8% when adjusted for exchange-rate effects. As for product ranges, HARTMANN recorded strong growth in modern wound care products, postoperative dressings and MediSet, the custom sets for outpatient and inpatient wound care.

The business of the negative-pressure wound therapy system offered under the Vivano brand developed dynamically. The consumer medical products in the first aid and diagnostic categories available in pharmacies were also increasingly well received by customers.

With sales revenues of EUR 632.4 million, the Incontinence Management segment was again the segment with the highest sales in 2013; the structural share in total sales was 35.2%. Compared to the previous year, growth was 0.5%, or 2.4% adjusted for exchange-rate effects.

Although the trend toward switching from incontinence briefs to lower-cost pads and fixation pants in nursing homes continued during the year under review, HARTMANN achieved growth in both product systems. In 2013, the company also benefited from good sales performance of MoliCare Mobile incontinence pants and mild incontinence pads of the MoliMed brand.

In fiscal year 2013, the Infection Management segment was the fastest growing segment of the HARTMANN GROUP with an increase of 3.4% to EUR 391.3 million. Adjusted for exchange-rate effects, the sales increase was 4.4%. In the product range for comprehensive infection prevention, the hand and surface disinfectants as well as the custom surgical sets offered under the CombiSet brand were the growth drivers.

Surgical clothes and drapes also performed well. In the year under review, the wide range of disposable surgical instruments received high acceptance by customers in inpatient and outpatient surgical settings.

In the three medical core segments, sales revenues rose by 1.9% to EUR 1,509.5 million. Sales growth adjusted for exchange-rate and acquisition effects was 3.3% and therefore above market growth. The share of the medical core business in consolidated sales was 84.1% and was thus approximately at the previous year’s level.

Click here to view full results.

HARTMANN